Sun Pharma Advanced Research Company

SPARC · NSE

— · —

₹206.21

Closing price — 31 Jul 2026

Market cap ₹5,403 Cr · EPS

Valuation

Blended fair value using DCF and peer comparison methods.

Insufficient data to compute intrinsic value for SPARC.

DCF is not applicable for this company. Intrinsic value based on peer comparison only.

No positive operating cash flow

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

No peer data available for SPARC.

Business quality

Valuation

P/E ratio

—

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

116.0%

ROCE

111.3%

ROA

—

Growth

Revenue CAGR (3yr)

98.9%

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

-4.9%

Dividend yield

—

Liquidity & Solvency

Debt / Equity

0.42×

Debt / EBITDA

—

Interest coverage

46.2×

Current ratio

2.47×

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Revenue

Net profit

Operating margin

Net margin

Revenue

₹1,879 Cr

Net profit

₹1,553 Cr

Operating margin

—

Net margin

82.7%

Revenue and net profit in ₹ Crores (left axis). Margins % on right axis.

Cash flow

Where cash comes from and where it goes.

Operating CFInvesting CFFinancing CFFree cash flow

Operating CF — Cash earned from running the business. The core engine of financial health.

Investing CF — Cash spent on assets and equipment. Negative is normal — it means the company is investing in growth.

Financing CF — Cash from borrowing or repaying loans and dividends. Negative means debt is being repaid.

Free cash flow — Operating CF minus capex. Cash left after keeping the business running. Positive and growing is ideal.

Operating CF

-₹238.77 Cr

Investing CF

₹0 Cr

Financing CF

₹0 Cr

Free cash flow

-₹262.6 Cr

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.

Equity

Debt

Current liabilities

Total assets

—

Total debt

₹556 Cr

Equity

₹1,339 Cr

Debt / Equity

0.42×

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.